Renalytix PLC

2O9

Company Profile

  • Business description

    Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease. Its product, KidneyIntelX, is designed to improve kidney disease diagnosis and prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery. The company's service, KidneyIntelX.dkd, enables the assessment of risk for early-stage chronic kidney disease progression. KidneyIntelX uses a proprietary algorithm combining blood-based biomarkers, inherited genetics, and electronic health record data to generate a patient risk score predicting rapid kidney function decline.

  • Contact

    2 Leman Street
    LondonE1W 9US
    GBR

    T: +44 2079338790

    https://www.renalytix.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Health Information Services

    Fiscal Year End

    30 June 2027

    Employees

    47

Stocks News & Analysis

stocks

ASX energy giant undervalued despite commissioning challenges

Near-term hurdles, long-term upside.
stocks

Undervalued ASX share upgrades guidance

Market share gains drive earnings upgrade despite a weak US housing backdrop.
stocks

ASX major bank drives strong quarterly profit

Profit momentum remains robust yet shares overvalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,112.0079.700.88%
CAC 408,428.0722.010.26%
DAX 4025,338.2122.82-0.09%
Dow JONES (US)52,531.97321.890.62%
FTSE 10010,850.1968.440.63%
HKSE25,310.85103.670.41%
NASDAQ24,602.99329.09-1.32%
Nikkei 22562,364.922,566.27-3.95%
NZX 50 Index13,861.9311.240.08%
S&P 5007,386.4926.69-0.36%
S&P/ASX 2008,947.8085.600.97%
SSE Composite Index3,813.3144.93-1.16%

Market Movers